Royal Bank Of Canada Covetrus, Inc. Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$20.69 - $20.91 $177,582 - $179,470	8,583 Added 78.45%	19,524 $407,000
Q2 2022 Aug 15, 2022	SELL	$13.8 - $20.82 $2.61 Million - $3.95 Million	-189,484 Reduced 94.54%	10,941 $227,000
Q1 2022 May 16, 2022	BUY	$15.96 - $18.87 $214,598 - $253,726	13,446 Added 7.19%	200,425 $3.37 Million
Q4 2021 Feb 14, 2022	SELL	$16.79 - $20.37 $385,582 - $467,797	-22,965 Reduced 10.94%	186,979 $3.73 Million
Q3 2021 Nov 15, 2021	BUY	$18.14 - $27.03 $906,346 - $1.35 Million	49,964 Added 31.23%	209,944 $3.81 Million
Q2 2021 Aug 16, 2021	BUY	$25.24 - $30.86 $4.04 Million - $4.94 Million	159,980 New	159,980 $4.32 Million

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.